We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Hyperspectral Imaging Detects Cancer During Surgery

By HospiMedica International staff writers
Posted on 26 Oct 2019
A smart surgical microscope that examines cells at the ultraviolet (UV) and near-infrared (NIR) spectrum could help identify cancer cells in the operating room (OR).

Developed by researchers University of Texas (UT) Southwestern Medical Centre (UTS; Dallas, TX, USA), the University of Texas at Dallas (UTD; Richardson, USA), and other institutions, the reflectance-based hyperspectral Imaging (HSI) and autofluorescence imaging microscope provides a non-ionizing optical imaging modality that can accurately detect and help reduce inadequate surgical margins during squamous cell carcinoma (SCC) within minutes, using deep learning and machine learning tools.

Image: Dr. Baowei Fei demonstrating HSI of tissue (Photo courtesy of UTD).
Image: Dr. Baowei Fei demonstrating HSI of tissue (Photo courtesy of UTD).

For the study, the researchers examined 102 excised tissue specimens. The tissue specimens were first imaged with reflectance-based HSI and autofluorescence imaging, and afterwards with two fluorescent dyes for comparison. The results showed that reflectance-based HSI and autofluorescence imaging could detect cancer at micrometer resolution, and outperformed both proflavin dye and standard red, green, and blue (RGB) images. Overall, HSU predicted the presence of cancer cells with 80-90% accuracy. The study was published on September 14, 2019, in the journal Cancers.

“We hope that this technology can help surgeons better detect cancer during surgery, reduce operating time, lower medical costs, and save lives. HSI is noninvasive, portable, and does not require radiation or a contrast agent,” concluded senior author Baowei Fei, PhD, EngD, of the UTS department of radiology, and colleagues. “If we have a large database that knows what is normal tissue and what is cancerous tissue, then we can train our system to learn the features of the spectra. Once it's trained, the smart device can predict whether a new sample is a cancerous tissue or not.”

HSI can help acquire large numbers of spectral bands throughout the electromagnetic spectrum (both within and beyond the visual range) with a very fine spatial resolution. So fine, in fact, that for every image pixel a full spectrum of color can be detected. Using this information and complex classification algorithms, it is possible to determine which material or substance is located in each pixel.

Related Links:
University of Texas (UT) Southwestern Medical Centre
University of Texas at Dallas


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Computerized Spirometer
DatospirAira

Latest Surgical Techniques News

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices